Increased sperm aneuploidy in two male carriers of germline TP53 mutations

Cancer Genetics

Volumn 204, Issue 5, 2011, Pages 278-281

  Paulasova, Petra ^a   Diblik, Jan ^a   Trkova, Marie ^a   Macek, Milan ^a   Sedlacek, Zdenek ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Fluorescence in situ hybridization; Li Fraumeni syndrome; TP53 gene

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; ANEUPLOIDY; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CASE REPORT; CHROMOSOME PAIRING; CHROMOSOME SEGREGATION; CONTROLLED STUDY; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GAMETOGENESIS; GENE MUTATION; GERM LINE; HOMOLOGOUS RECOMBINATION; HUMAN; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SEMEN ANALYSIS; SEX CHROMOSOME; SPERMATOGENESIS; SPERMATOGONIUM; TUMOR SUPPRESSOR GENE; TURNER SYNDROME; GENETICS; HETEROZYGOTE; IN SITU HYBRIDIZATION; MUTATION; SPERMATOZOON; SPERMATOZOON COUNT;

ADULT; ANEUPLOIDY; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IN SITU HYBRIDIZATION; LI-FRAUMENI SYNDROME; MALE; SPERM COUNT; SPERMATOZOA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80051596530     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.03.003     Document Type: Article

References (27)

1. Li F.P., Fraumeni J.F. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Ann Intern Med 1969, 71:747-752.
2. Li F.P., Fraumeni J.F., Mulvihill J.J., et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988, 48:5358-5362.
3. Malkin D., Li F.P., Strong L.C., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238.
4. Beumer T.L., Roepers-Gajadien H.L., Gademan I.S., et al. The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ 1998, 5:669-677.
5. Marty M.S., Singh N.P., Stebbins K.E., et al. Initial insights regarding the role of p53 in maintaining sperm DNA integrity following treatment of mice with ethylnitrosourea or cyclophosphamide. Toxicol Pathol 2010, 38:244-257.
6. Rotter V., Schwartz D., Almon E., et al. Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc Natl Acad Sci USA 1993, 90:9075-9079.
7. Odorisio T., Rodriguez T.A., Evans E.P., et al. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat Genet 1998, 18:257-261.
8. Schwartz D., Goldfinger N., Kam Z., et al. p53 controls low DNA damage-dependent premeiotic checkpoint and facilitates DNA repair during spermatogenesis. Cell Growth Differ 1999, 10:665-675.
9. Yin Y., Stahl B.C., DeWolf W.C., et al. p53-mediated germ cell quality control in spermatogenesis. Dev Biol 1998, 204:165-171.
10. Habu T., Wakabayashi N., Yoshida K., et al. p53 Protein interacts specifically with the meiosis-specific mammalian RecA-like protein DMC1 in meiosis. Carcinogenesis 2004, 25:889-893.
11. Lu W.J., Chapo J., Roig I., et al. Meiotic recombination provokes functional activation of the p53 regulatory network. Science 2010, 328:1278-1281.
12. Paul C., Povey J.E., Lawrence N.J., et al. Deletion of genes implicated in protecting the integrity of male germ cells has differential effects on the incidence of DNA breaks and germ cell loss. PLoS ONE 2007, 2:e989.
13. Armstrong J.F., Kaufman M.H., Harrison D.J., et al. High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995, 5:931-936.
14. Duensing A., Duensing S. Guilt by association? p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun 2005, 331:694-700.
15. Sedlacek Z., Kodet R., Poustka A., et al. A database of germline p53 mutations in cancer-prone families. Nucl Acids Res 1998, 26:214-215.
16. Pivnick E.K., Furman W.L., Velagaleti G.V., et al. Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation. J Med Genet 1998, 35:328-332.
17. Krutilkova V., Trkova M., Fleitz J., et al. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 2005, 41:1597-1603.
18. Martini E., Speel E.J., Geraedts J.P., et al. Application of different in-situ hybridization detection methods for human sperm analysis. Hum Reprod 1995, 10:855-861.
19. Liehr T., Pellestor F. Molecular cytogenetics: the standard FISH and PRINS procedure. Fluorescence in situ hybridisation (FISH) - application guide 2009, 23-34. Springer, Berlin. T. Liehr (Ed.).
20. Egozcue J., Blanco J., Vidal F. Chromosome studies in human sperm nuclei using fluorescence in-situ hybridization (FISH). Hum Reprod Update 1997, 3:441-452.
21. Hartley A.L., Birch J.M., Blair V., et al. Foetal loss and infant deaths in families of children with soft-tissue sarcoma. Int J Cancer 1994, 56:646-649.
22. Templado C., Bosch M., Benet J. Frequency and distribution of chromosome abnormalities in human spermatozoa. Cytogenet Genome Res 2005, 111:199-205.
23. Chandrakanthan V., Chami O., Stojanov T., et al. Variable expressivity of the tumour suppressor protein TRP53 in cryopreserved human blastocysts. Reprod Biol Endocrinol 2007, 5:39.
24. Vanneste E., Voet T., Le Caignec C., et al. Chromosome instability is common in human cleavage-stage embryos. Nat Med 2009, 15:577-583.
25. Martinez-Pasarell O., Nogues C., Bosch M., et al. Analysis of sex chromosome aneuploidy in sperm from fathers of Turner syndrome patients. Hum Genet 1999, 104:345-349.
26. Rubes J., Vozdova M., Oracova E., et al. Individual variation in the frequency of sperm aneuploidy in humans. Cytogenet Genome Res 2005, 111:229-236.
27. Tempest H.G., Ko E., Rademaker A., et al. Intra-individual and inter-individual variations in sperm aneuploidy frequencies in normal men. Fertil Steril 2009, 91:185-192.